Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Akero Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 4 | -$1.01 | -$0.90 | -$0.97 |
| Q2 2025 | 2 | -$1.01 | -$1.01 | -$1.01 |
| Q3 2025 | 2 | -$1.08 | -$1.08 | -$1.08 |
| Q4 2025 | 3 | -$1.16 | -$1.16 | -$1.16 |
Akero Therapeutics, Inc. Earnings Date And Information
Akero Therapeutics, Inc. last posted its earnings results on Friday, February 28th, 2025. The company reported $-0.99 earnings per share for the quarter, missing analysts' consensus estimates of $-0.98 by $0.01. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Akero Therapeutics, Inc. has generated $-4 earnings per share over the last year ($-3.75 diluted earnings per share) and currently has a price-to-earnings ratio of -10.46. Akero Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based on prior year's report dates.
Akero Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/28/2025 | Q4 2024 | -$0.98 | -$0.99 | -0.01 | $0 | $0 |
| 11/08/2024 | Q3 2024 | -$0.90 | -$1.05 | -0.15 | $0 | $0 |
| 08/09/2024 | Q2 2024 | -$0.90 | -$0.81 | 0.09 | $0 | $0 |
| 05/10/2024 | Q1 2024 | -$0.90 | -$0.90 | 0 | N/A | $0 |
| 02/29/2024 | Q4 2023 | -$0.82 | -$0.99 | -0.17 | N/A | $284,000 |
| 11/13/2023 | Q3 2023 | -$0.69 | -$0.71 | -0.02 | N/A | $0 |
| 08/10/2023 | Q2 2023 | -$0.62 | -$0.60 | 0.02 | N/A | $0 |
| 05/15/2023 | Q1 2023 | -$0.62 | -$0.50 | 0.12 | N/A | $0 |
| 03/17/2023 | Q4 2022 | -$0.78 | -$0.44 | 0.34 | N/A | $0 |
| 11/04/2022 | Q3 2022 | -$0.73 | -$0.91 | -0.18 | N/A | $0 |
| 08/04/2022 | Q2 2022 | N/A | -$0.77 | N/A | N/A | $0 |
| 05/06/2022 | Q1 2022 | -$0.85 | -$0.74 | 0.11 | N/A | $0 |
| 02/25/2022 | Q4 2021 | -$0.81 | -$0.93 | -0.12 | N/A | $0 |
| 11/12/2021 | Q3 2021 | -$0.91 | -$0.70 | 0.21 | N/A | $0 |
| 08/13/2021 | Q2 2021 | -$0.72 | -$0.83 | -0.11 | N/A | $0 |
| 05/13/2021 | Q1 2021 | -$1.01 | -$0.43 | 0.58 | N/A | $0 |
| 03/16/2021 | Q4 2020 | -$0.72 | -$0.86 | -0.14 | N/A | $0 |
| 11/12/2020 | Q3 2020 | -$0.48 | -$0.63 | -0.15 | N/A | $0 |
| 08/12/2020 | Q2 2020 | -$0.48 | -$0.57 | -0.09 | N/A | $0 |
| 05/13/2020 | Q1 2020 | -$0.60 | -$0.42 | 0.18 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Akero Therapeutics, Inc. Earnings: FAQ's
Akero Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based offlast year's report dates.
The conference call for Akero Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Akero Therapeutics, Inc.'s latest earnings report can be read online.
Akero Therapeutics, Inc. (:AKRO) has a recorded net income of $-252,060,000.Akero Therapeutics, Inc. has generated $-3.75 earnings per share over the last four quarters.
Akero Therapeutics, Inc. (:AKRO) has a price-to-earnings ratio of -10.46 and price/earnings-to-growth ratio is -0.1.